Monitor for any subsequent equity offering or at-the-market (ATM) program that utilizes the newly authorized shares, which would signal near-term dilution. The expanded incentive plan evergreen provision also increases potential future dilution from equity compensation.
Price Chart
Executive Summary
iBio, Inc. held its 2026 Annual Meeting on October 14, 2026, where stockholders approved an increase in authorized common shares from 275,000,000 to 500,000,000 and amended the 2023 Omnibus Incentive Plan to expand its evergreen share reserve. The authorized share increase provides headroom for future equity issuances, while the plan amendment allows for ongoing equity compensation grants. This is a routine governance filing with no financial results or operational updates.
Key Facts
- Stockholders approved increasing authorized common shares from 275,000,000 to 500,000,000.
- Stockholders approved Amendment No. 1 to the 2023 Omnibus Incentive Plan, modifying the evergreen provision through 2033.
- Two Class III directors (William Clark and Gary Sender) were elected with overwhelming support.
- Grassi & Co., CPAs, P.C. was ratified as independent auditor for fiscal year ending June 30, 2027.
- Say-on-pay proposal was approved on an advisory basis.
- 48,244,264 shares were represented at the meeting, constituting a quorum.
Financial Impact
No financial figures reported. The authorized share increase from 275M to 500M shares provides capacity for future equity issuance but does not represent an immediate dilutive event.
Risk Factors
- Increased authorized shares create capacity for future dilutive equity issuances without additional stockholder approval.
- Expanded evergreen provision in the incentive plan may lead to higher share-based compensation expense over time.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001420720-26-000032 |
| Document: ibio-ex3d1.htm | 0001420720-26-000032 |
| Document: ibio-ex10d1.htm | 0001420720-26-000032 |
| Document: 0001420720-26-000032-index-headers.html | 0001420720-26-000032 |
| Document: 0001420720-26-000032-index.html | 0001420720-26-000032 |
| Document: 0001420720-26-000032.txt | 0001420720-26-000032 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 8-K | $0.8210 | awaiting T+5 | — | $0.7100 (−13.52%) |
Oct 14, 2026 12d ago | SC 13G | $0.7808 $0.8400 | ▲ +7.58% | ▲ +7.13% | $0.7100 (−9.07%) |
Oct 13, 2026 13d ago | 8-K | $0.7818 $0.8210 | ▲ +5.01% | ▲ +6.17% | $0.7100 (−9.18%) |
Sep 14, 2026 6w ago | 8-K | $1.19 $1.33 | ▲ +11.76% | ▲ +9.64% | $0.7100 (−40.34%) |
Aug 28, 2026 8w ago | 8-K | $1.36 $1.31 | ▼ −3.68% | ▼ −3.79% | $0.7100 (−47.79%) |
Aug 28, 2026 8w ago | Press Release | $1.36 $1.31 | ▼ −3.68% | ▼ −3.79% | $0.7100 (−47.79%) |
Jul 1, 2026 16w ago | 8-K | $1.75 $1.59 | ▼ −9.14% | ▼ −9.40% | $0.7100 (−59.43%) |
May 15, 2026 23w ago | 3 | $1.47 $1.84 | ▲ +25.17% | ▲ +24.21% | $0.7100 (−51.70%) |
May 12, 2026 23w ago | Press Release | $1.55 $1.50 | ▲ +3.23% | ▲ +2.07% | $0.7100 (+54.19%) |
May 8, 2026 24w ago | 8-K | $1.66 $1.42 | ▼ −14.46% | ▼ −14.37% | $0.7100 (−57.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers